Canaan Research & Investment

https://www.canaanrd.com

Mirnax Biosens, S.L. (Mirnax) is a biotechnology company owned by Canaan Research & Investment, focused on the development of new disruptive technologies based on liquid biopsy, for clinical diagnosis and prognosis. Mirnax is developing a universal and innovative platform for the validation of genetic biomarkers of different biological nature (DNA, RNA, miRNAs, lncRNA, etc.) to market a technology, based on microqPCR, that can give a personalized diagnostic and prognostic response in a fast and effective way. This new Mirnax technology gives rise to the development of different diagnostic and prognostic kits that are unique and innovative in the current market and generate a personalized response to each patient. Our company owns several biomarker panels with clinical value and excellent commercial perspectives. They allow the development of kits for pathologies with high incidence in the current population and for which there are no diagnosis and prognosis options. Among them, there is a panel of biomarkers for the early diagnosis of Acute Kidney Injury in the early stages, which has been developed in collaboration with IRYCIS; a biomarker to know the response to treatment in patients with Rheumatoid Arthritis, developed with the IMIBIC and a biomarker to diagnose asthma, developed in collaboration with the Jiménez Díaz Foundation. In addition, the company has developed, in collaboration with Complutense University of Madrid, an automated detection device (electrochemical biosensor), with which several blood biomarkers have been validated for diseases such as cancer, cardiomyopathies, rheumatoid arthritis, asthma, kidney injury or liver failure, as well as another series of biomarkers to detect oral cancer (mouth, lips, tongue or salivary glands cancer) directly from a saliva sample. *

	Start	2019-07-16 existent
	Industry	venture capital
	Industry 2	LIFE SCIENCES

	Region	Madrid
	Country	Spain (España)
	Street	8 C/ Orense Oficinas - 1º planta
	City	28020 Madrid
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Arcis Biotechnology Ltd.. (7/16/19). "Press Release: Arcis Biotechnology and Mirnax Biosens Sign Exclusive License Agreement for Arcis Sample Prep Technology". Daresbury & Madrid.

		Record changed: 2020-08-04